Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Neogen Q4 revenue beats on food safety segment growth

Neogen Q4 revenue beats on food safety segment growth

ReutersReuters2026/07/30 11:43


Overview

  • U.S. food safety solutions firm's fiscal Q4 revenue flat yr/yr, beating analyst expectations

  • Adjusted EPS and adjusted net income for Q4 beat analyst expectations

  • Adjusted EBITDA margin rose to 20.2% from 18.0%, aided by cost initiatives and gross margin gains


Outlook

  • Neogen sees FY27 revenue between $880 mln and $885 mln, including Genomics division contribution

  • Company expects FY27 adjusted EBITDA of $180 mln to $182 mln, including Genomics division

  • Neogen guides Q1 FY27 revenue to $207 mln-$209 mln and adjusted EBITDA to about $37 mln


Result Drivers

  • FOOD SAFETY SEGMENT - Core Food Safety revenue grew 5.8% in Q4, the highest rate since FY23, driven by strong gains in Indicator Testing, Culture Media, and Bacterial and General Sanitation

  • ANIMAL SAFETY SUPPLY CHAIN - Animal Safety revenue remained down year-over-year but rose 7% sequentially as supply-related challenges were largely resolved

  • MARGIN IMPROVEMENT - Gross margin and adjusted gross margin rose, helped by favorable product mix and pricing changes


Company press release: ID:nBw5KtZKya


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Beat

$225.30 mln

$212.36 mln (4 Analysts)

Q4 Adjusted EPS

Beat

$0.09

-$0.07 (4 Analysts)

Q4 Loss Per Share

$0.05

Q4 Adjusted Net Income

Beat

$18.70 mln

-$14.04 mln (4 Analysts)

Q4 Net Loss

$11.30 mln

Q4 Adjusted EBITDA

Beat

$45.40 mln

$42.23 mln (4 Analysts)

Q4 Adjusted EBITDA Margin

20.20%


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

  • Wall Street's median 12-month price target for Neogen Corp is $11.50, about 22.3% above its July 29 closing price of $9.40


Reuters Recommended Reads

  • July 28 - Ecolab raises annual profit forecast on pricing, high-tech demand

  • July 29 - Avantor Q2 results beat, raises 2026 outlook

  • July 29 - Cyclosporiasis cases in Michigan surpass 10,000 in ongoing outbreak


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!